BetterLife Pharma ($BETRF) targeting mental disorders w/ BETR-001 (neuroplastogenic for MDD/anxiety/neuropathic pain) + BETR-002 (anxiety/benzo dependency)—no trip, all therapeutic upside!
Micro-cap beast (~$7M mkt cap, tight float) stacking catalysts: Recent insider options grants, YAFO Capital Asia partnering push during JPM week, strong chart holds + volume teasing breakout from $0.04 lows. Traders calling it "good looking" with forecast upside!
Undervalued in hot mental health/biotech narrative—volume building, dip buyers loading?
Who's jumping on $BETRF? Drop your entry price or target below ????????
$0.10+ squeeze run soon? Or $0.20+ on partnership/news momentum?
Check buzz: https://www.youtube.com/watch?v=4CexnLxXKmM&t=1s